GlassScriptPhysician profile
Randall L Dyk
NPI 1033199674
$912.34
in general payments reported to CMS, 2019-2025
20 companies · $77.33 in 2025
The $77.33 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $15.81 · 2023: $83.25 · 2024: $425 · 2025: $77.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $118.12 | 2023-2025 | Gardasil 9, Vaxelis, Proquad |
| Ironshore Pharmaceuticals INC. | $109.12 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $93.78 | 2024 | Qelbree |
| Sanofi Pasteur INC. | $77.55 | 2019-2024 | |
| Glaxosmithkline, LLC. | $71.66 | 2019-2024 | Bexsero |
| Tris Pharma INC | $60.83 | 2019 | |
| Pfizer INC. | $50.66 | 2024-2025 | |
| Phadia US INC. | $44.96 | 2019-2024 | Immunocap |
| Neurelis, INC. | $37.69 | 2024 | Valtoco |
| Vertical Pharmaceuticals, LLC | $33.49 | 2019 | |
| Neos Therapeutics, LP | $29.16 | 2019-2020 | |
| Shire North American Group INC | $27.92 | 2019 | |
| Kaleo, INC. | $26.18 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.90 | 2024 | Gattex |
| Sanofi-Aventis U.S. LLC | $22.28 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $18.96 | 2023 | |
| Daiichi Sankyo INC. | $18.11 | 2024 | Injectafer |
| Cranial Technologies, INC | $17.43 | 2024 | Doc Band |
| Collegium Pharmaceutical, INC. | $17.36 | 2025 | Jornay Pm |
| Alexion Pharmaceuticals, INC. | $13.18 | 2024 | Koselugo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Dyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.